PI3K — Drug Target
All drugs that target PI3K — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
PI3K inhibitor · PI3K/mTOR inhibitor
Phase 3 pipeline (19)
- PLC · Sigma-Tau Research, Inc. · PI3K inhibitor · Oncology
PLC is a drug that targets the PI3K/AKT pathway. - 1PC111 · Orient Pharma Co., Ltd. · PI3K inhibitor · Oncology
This drug is a small molecule that targets the PI3K/AKT pathway. - SHR0302 · Jiangsu HengRui Medicine Co., Ltd. · PI3K inhibitor · Oncology
SHR0302 is a small molecule that targets the PI3K/AKT/mTOR pathway. - D-2570 · InventisBio Co., Ltd · PI3K inhibitor · Oncology
D-2570 is a small molecule that targets the PI3K/AKT pathway. - 1PC002 · Orient Pharma Co., Ltd. · PI3K inhibitor · Oncology
This drug is a small molecule that targets the PI3K/AKT/mTOR pathway. - NALIRI · Cancer Institute and Hospital, Chinese Academy of Medical Sciences · PI3K inhibitor · Oncology
NALIRI is a small molecule that targets the PI3K/AKT/mTOR pathway. - AG20012 · Ahn-Gook Pharmaceuticals Co.,Ltd · PI3K inhibitor · Oncology
AG20012 is a small molecule that targets the PI3K/AKT/mTOR pathway. - AD-2091 · Addpharma Inc. · PI3K inhibitor · Oncology
AD-2091 is a small molecule that targets the PI3K/AKT pathway to inhibit cancer cell growth. - TCA108 · EMS · PI3K inhibitor · Oncology
TCA108 is a small molecule that targets the PI3K/AKT/mTOR pathway. - Haporine-S · DH Bio Co., Ltd. · PI3K inhibitor · Oncology
Haporine-S is a small molecule that targets the PI3K/AKT/mTOR pathway. - Prodiax-23 · SK Chemicals Co., Ltd. · PI3K inhibitor · Oncology
Prodiax-23 is a small molecule that targets the PI3K/AKT pathway. - AD-2021 · Addpharma Inc. · PI3K inhibitor · Oncology
AD-2021 is a small molecule that targets the PI3K/AKT pathway to inhibit cancer cell growth. - D-1553 · InventisBio Co., Ltd · PI3K inhibitor · Oncology
D-1553 is a small molecule that targets the PI3K/AKT/mTOR pathway. - SBR759A · Novartis · PI3K inhibitor · Oncology
SBR759A is a small molecule that targets the PI3K pathway. - GDC-229 · Balmoral Medical company · PI3K inhibitor · Oncology
GDC-229 is a small molecule targeting the PI3K pathway. - AG20011 · Ahn-Gook Pharmaceuticals Co.,Ltd · PI3K inhibitor · Oncology
AG20011 is a small molecule targeting the PI3K/AKT/mTOR pathway. - YK-209A tablet · Suzhou Puhe Pharmaceutical Technology Co., LTD · PI3K inhibitor · Oncology
YK-209A tablet is a small molecule that targets the PI3K/AKT signaling pathway. - AD-2022 · Addpharma Inc. · PI3K inhibitor · Oncology
AD-2022 is a small molecule that targets the PI3K/AKT pathway. - AD-2281 · Addpharma Inc. · PI3K inhibitor · Oncology
AD-2281 is a small molecule that targets the PI3K/AKT pathway.
Phase 2 pipeline (18)
- AON-D21 · Aptarion Biotech AG · PI3K inhibitor · Oncology
AON-D21 is a small molecule that targets the PI3K/AKT/mTOR pathway. - BCD-236 · Biocad · PI3K inhibitor · Oncology
BCD-236 is a small molecule that targets the PI3K/AKT pathway. - AGA2115 · Angitia Incorporated Limited · PI3K inhibitor · Oncology
AGA2115 is a small molecule drug that targets the PI3K/AKT/mTOR pathway. - DA-001 · Applied Biology, Inc. · PI3K inhibitor · Oncology
DA-001 is a small molecule that targets the PI3K/AKT pathway. - AB1010 · AB Science · PI3K inhibitor · Oncology
AB1010 is a small molecule that targets the PI3K pathway. - BB-031 · Basking Biosciences, Inc. · PI3K inhibitor · Oncology
BB-031 is a small molecule that targets the PI3K pathway. - CAL-101 · German CLL Study Group · PI3K inhibitor · Oncology
CAL-101 is a selective, irreversible inhibitor of phosphatidylinositol 3-kinase (PI3K). - MBM-02 · Matrix Biomed, Inc. · PI3K inhibitor · Oncology
MBM-02 is a small molecule that targets the PI3K/AKT pathway. - BB-101 · Blue Blood Biotech Corp. · PI3K inhibitor · Oncology
BB-101 is a small molecule that targets the PI3K pathway. - BEY2153 · BeyondBio Inc. · PI3K inhibitor · Oncology
BEY2153 is a small molecule that targets the PI3K pathway. - GEn-1124 · GEn1E Lifesciences · PI3K inhibitor · Oncology
GEn-1124 is a small molecule that targets the PI3K/AKT pathway. - B007 · Shanghai Jiaolian Drug Research and Development Co., Ltd · PI3K inhibitor · Oncology
B007 is a small molecule that targets the PI3K/AKT signaling pathway. - AG-73305 · Allgenesis Biotherapeutics Inc. · PI3K/mTOR inhibitor · Oncology
AG-73305 is a small molecule inhibitor of the PI3K/AKT/mTOR pathway. - AMOR-1 · Amorphical Ltd. · PI3K inhibitor · Oncology
AMOR-1 is a small molecule that targets the PI3K/AKT signaling pathway. - AZD8931 · AstraZeneca · PI3K inhibitor · Oncology
AZD8931 is a PI3K inhibitor. - AEVI-001 · Aevi Genomic Medicine, LLC, a Cerecor company · PI3K inhibitor · Oncology
AEVI-001 is a small molecule drug that targets the PI3K/AKT pathway. - AlphaMedix · Orano Med LLC · PI3K inhibitor · Oncology
AlphaMedix is a small molecule that targets the PI3K/AKT pathway to inhibit cancer cell proliferation. - BA3021 · Canadian Cancer Trials Group · PI3K inhibitor · Oncology
BA3021 is a small molecule targeting the PI3K pathway.